TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck.

T Y Seiwert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.